NIFTY 50
24,565.35 (-0.82%)
NIFTY IT
34,649.60 (-1.85%)
NIFTY AUTO
23,410.95 (-1.04%)
NIFTY FINANCIAL SERVICES
26,492.50 (-0.59%)
NIFTY BANK
55,617.60 (-0.62%)
NIFTY REALTY
896.15 (-1.78%)
NIFTY ENERGY
34,889.00 (-0.65%)
NIFTY METAL
9,102.35 (-1.97%)
NIFTY FMCG
56,197.05 (0.69%)
NIFTY HEALTH CARE
14,468.70 (-2.77%)
NIFTY PHARMA
22,011.70 (-3.33%)
NIFTY MEDIA
22,011.70 (-3.33%)
Platforms
Webinars
Insights
Research
Videos
Markets
Equity
Derivatives
IPO
Other Markets
Corporate Information
Pricing
Support
Backoffice
Open an Account
Home
Platform
Insights
Research
Markets
Pricing
Support
Backoffice
Open an Account
Trend of Stock Market
A trend is the broad upward or downward movement of a stock's price over time
Forthcoming IPO
Open Issues
Closed Issue
Top Gainers / Losers
52 Weeks High/ Low
Value / Volume Toppers
Get Quotes
Nifty Futures
Top Traded Quantity
Top Traded Value
Derivative Summary
Daily Settlement Price
List Of Underlying
Put Call Ratio
FII Statistics
Most Active Contract
All Index Futures
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Most Active Calls
Most Active Put
Top Gainers
Top Losers
Highest In OI
Lowest In OI
Increase In OI
Decrease In OI
Forthcoming Issues
Open Issues
Closed Issue
World Indices
ADR Prices
MF Investment
FII Investment
Get Quotes
Company Snapshot
Company Background
Board of Directors
Directors Reports
Profit & Loss
Balance Sheet
Quarterly Results
Shareholding Pattern
Key Financial Ratios
Mutual Fund Holdings
Peer Comparison
Technical Chart
Company News
Change Company Name
Dr Lal Pathlabs Ltd
Healthcare
BSE Code
539524
ISIN Demat
INE600L01024
Book Value
254.78
NSE Symbol
LALPATHLAB
Dividend Yield (%)
0.75
Market Cap (
₹
Cr.)
26,599.14
P/E
51.32
EPS
61.87
Face Value
10
Date
Headline
31-Jul-25
Board of Dr. Lal PathLabs recommends interim dividend
24-Jul-25
Dr. Lal PathLabs to convene board meeting
25-Jun-25
Dr Lal Pathlabs strengthens its genomics capabilities with Illumina's NovaSeq™ X Series
25-Apr-25
Dr. Lal PathLabs to convene AGM
19-Apr-25
Dr. Lal PathLabs schedules board meeting
15-Apr-25
Dr Lal Pathlabs introduces highly specialized Amyloidosis test
18-Feb-25
Dr Lal Pathlabs allots 4,000 equity shares under ESOP
30-Jan-25
Board of Dr. Lal PathLabs recommends Third Interim dividend
23-Jan-25
Dr. Lal PathLabs to conduct board meeting
18-Dec-24
Dr Lal Pathlabs allots 5,483 equity shares under ESOP
Prev
1
2
3
Next